Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells are increased with age and elevated in donors with a history of cancer; an age-related effect has never been shown in humans. As we age, the composition of our peripheral leukocytes changes dramatically. Many of these alterations contribute to the general immune dysfunction that burdens the elderly, which in turn, contributes to increased susceptibility to disease. MDSCs represent a heterogeneous population of immunosuppressive leukocytes that are elevated in the peripheral blood of cancer patients. Given the relation between cancer incidence and age, this study examined the frequency of peripheral blood CD33(+)HLA-DR(−) MDSCs across three cohorts: healthy adults (19–59 years old), community-dwelling seniors (61–76 years old), and frail elderly (67–99 years old). This analysis is the first to demonstrate that MDSCs and specifically the CD11b(+)CD15(+) MDSC subset are increased with age. Proinflammatory cytokines that are required for the differentiation of MDSCs (e.g., TNF-α, IL-6, and IL-1β) were similarly found to be increased in the serum of the frail elderly. Furthermore, the proportion of MDSCs and the CD11b(+)CD15(+) subset were found to be elevated significantly in elderly donors with a history of cancer. This age-related elevation in the frequency of MDSCs may contribute to the increased cancer incidence that occurs with age. Further investigation into the functional consequences of elevated MDSCs will provide valuable insight into the progression of age-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is elevated with age and coincides with increases in both circulating immunosuppressive myeloid cells and cancer incidence26.”
From Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“sive, myeloid lineage cells in the peripheral blood [4].”
BackgroundDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215 · cited 1×
“been found to be associated with clinical scores, such as tumor stage, burden, and metastasis [10, 15].”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863 · cited 1×
“[19]).”
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862 · cited 8×
“MDSCs (CD33 HLA-DR ) and the CD11b CD15 MDSC subset were found to be increased significantly in seniors (0.29 0.03 and 0.17 0.03, respectively) and the frail elderly (0.40 0.03 and 0.29 0.02, respectively) as compared with healthy adults (0.22 0.03 and 0.11 0.03, respectively; Fig.”
BackgroundInfluentialLechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582 · cited 2×
“Furthermore, serum IL-6 has been shown to be correlated with MDSC frequency in patients with gastrointestinal cancer [20], and as mentioned above, proinflammatory cytokines are able to induce the differentiation of MDSCs in vitro [5, 8, 21].”
BackgroundRockwood, K., Song, X., & Mitnitski, A. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101271 · Cited by 573
Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W., Maisa, A., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00851.x · Cited by 547
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Inflammaging: disturbed interplay between autophagy and inflammasomes
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2012) · Aging · doi:10.18632/aging.100444 · Cited by 453
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398 · cited 1×
“categories [6, 7].”
Research works printed but not linked: 1
- U.S. Census Bureau (2001) The 65 Years and Older Population: 2000. Census 2000 Brief. U.S. Census Bureau, Washington, DC
Cited by
Items 101–200 of 235
Salminen, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102694 · Cited by 34
“…that during the aging process, the numbers of MDSCs significantly increase in the circulation and in diverse tissues, such as the BM, spleen, lymph nodes, heart, and skin (Enioutina et al., 2011; Verschoor et al., 2013; Ruhland et al., 2016; Flores et al., 2017; Li et al., 2021; Sun et al., 2021).”
Jackaman, C., & Nelson, D. J. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.11.009 · Cited by 31
Recent advances in myeloid-derived suppressor cell biology
Yaseen, M. M., Abuharfeil, N. M., Darmani, H., & Daoud, A. K. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0797-2 · Cited by 33
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity
Baiden-Amissah, R. E. M., & Tuyaerts, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143586 · Cited by 30
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
Jackaman, C., Dye, D. E., & Nelson, D. J. (2014) · AGE · doi:10.1007/s11357-014-9655-y · Cited by 33
“Therefore, increasing immunosuppression during healthy aging could be a normal phenomenon in mice and, as shown by others, likely in humans as well (Gregg et al. 2005; Verschoor et al. 2013).”
Immunotherapy in older patients with hepatocellular carcinoma
Lyu, N., Yi, J., & Zhao, M. D. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.11.024 · Cited by 31
Schrijver, I. T., Karakike, E., Théroude, C., Baumgärtner, P., Harari, A., Giamarellos‐Bourboulis, E. J., Calandra, T., & Roger, T. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00431-0 · Cited by 33
Kasherman, L., Siu, D. H. W., Lee, K., Lord, S. J., Marschner, I. C., Lewis, C. R., Friedlander, M. L., & Lee, C. K. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.05.013 · Cited by 32
GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process
Salminen, A. (2024) · Biogerontology · doi:10.1007/s10522-024-10164-0 · Cited by 35
Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer
Ostrand‐Rosenberg, S. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042120-105240 · Cited by 27
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
Frosch, J., Leontari, I., & Anderson, J. (2021) · Cancers · doi:10.3390/cancers13071743 · Cited by 29
Immunosenescence in the nursing home elderly
Johnstone, J., Millar, J., Lelic, A., Verschoor, C. P., Walter, S. D., Devereaux, P. J., Bramson, J. L., & Loeb, M. B. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-50 · Cited by 27
Self-citationPark, S. J., & Bejar, R. L. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0133-9 · Cited by 30
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
“…AD risk genes that promote immune AD risk genes that drive immunemetabolicalterations Several of these genes were reported to promote myeloid cell transition to MDSCs 198,202,208,214,216,218,219,222,223,235,264,265,284,348–350 , whereas others were associated with inhibition of MDSCs 192,194,284 .”
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
Bahlool, A. Z., Grant, C., Cryan, S., Keane, J., & O’Sullivan, M. P. (2022) · Current Research in Immunology · doi:10.1016/j.crimmu.2022.03.003 · Cited by 33
The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
Salminen, A. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02360-1 · Cited by 28
Sekido, K., Tomihara, K., Tachinami, H., Heshiki, W., Sakurai, K., Moniruzzaman, R., Imaue, S., Fujiwara, K., & Noguchi, M. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104462 · Cited by 23
Choi, J., Suh, Y., Choi, Y., Han, J., Kim, T. H., Park, S., Kong, S., Lee, H., & Yang, H. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4510-4 · Cited by 24
Senescence and Aging: Does It Impact Cancer Immunotherapies?
Maggiorani, D., & Beausejour, C. M. (2021) · Cells · doi:10.3390/cells10071568 · Cited by 25
Myeloid-derived suppressor cells promote age-related increase of lung cancer growth via B7-H1
Chen, S., Liu, H., Su, N., Zhang, G., & Wang, L. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.001 · Cited by 23
“Verschoor found an age-related increase of MDSCs in the peripheral blood of cancer patients, which was positively correlated with tumor incidence (Verschoor et al., 2013).”
BackgroundSingh, S., Barr, H. L., Liu, Y., Robins, A., Heeb, S., Williams, P. M., Fogarty, A., Cámara, M., & Martínez‐Pomares, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117447 · Cited by 31
Lelic, A., Verschoor, C. P., Lau, V. W. C., Parsons, R., Evelegh, C. M., Bowdish, D. M. E., Bramson, J. L., & Loeb, M. B. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw462 · Cited by 27
Self-citationMyeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
Tomela, K., Pietrzak, B., Galus, Ł., Mackiewicz, J., SCHMIDT, M. T., Mackiewicz, A. A., & Kaczmarek, M. (2023) · Cells · doi:10.3390/cells12050789 · Cited by 26
“recruited much older participants (over 61 to 99 years old) [42], however, our results indicate some differences observed in younger groups of healthy participants which can also be informative.”
BackgroundResultThe role of myeloid derived suppressor cells in musculoskeletal disorders
Ren, Y., Bäcker, H. C., Müller, M., & Kienzle, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139683 · Cited by 25
The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer
Gomes, F., Tay, R. Y., Chiramel, J., & Califano, R. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0573-z · Cited by 23
Xiao, C., Chi, L., Lin, T., Liang, F., Pei, Z., Sun, J., & Teng, W. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02743-8 · Cited by 24
“A previous study demonstrates that MDSCs are increased in blood in healthy elderly individuals compared with young individuals [34].”
BackgroundEffects of tumor grade and dexamethasone on myeloid cells in patients with glioma
Moyes, K. W., Davis, A. D., Hoglund, V. J., Haberthur, K., Lieberman, N. A. P., Kreuser, S. A., Deutsch, G. H., Franco, S., Locke, D., Carleton, M. O., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1507668 · Cited by 23
Nonnenmann, J., Stirner, R., Roider, J., Jung, M. C., Schrödl, K., Bogner, J. R., & Draenert, R. (2014) · Journal of Virology · doi:10.1128/jvi.00113-14 · Cited by 19
“Recently, it has been described that G-MDSC levels increase with age in healthy individuals (14) and that HLA-DR CD14 MDSC populations isolated from healthy donors can inhibit proliferation of autologous CD4 T cells (9).”
BackgroundPerfilyeva, Y. V., Abdolla, N., Ostapchuk, Y. O., Tleulieva, R., Krasnoshtanov, V. C., Perfilyeva, A. V., & Belyaev, N. N. (2018) · Inflammation · doi:10.1007/s10753-018-0892-6 · Cited by 19
Zhaoa, I.-M., Xua, H.-J., Kanga, X., Zhaoa, A.-M., & Luc, L.-M. (2016) · Cited by 19
Kobayashi, T., Nagata, M., Hachiya, T., Wakita, H., Ikehata, Y., Takahashi, K., China, T., Shimizu, F., Lü, J., Jin, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372771 · Cited by 20
Treatment of Glioblastoma in the Elderly
Harrison, R. A., & de Groot, J. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0568-9 · Cited by 18
Recent advances in regulatory immune cells: exploring the world beyond Tregs
Shi, P., Yu, Y., Xie, H., Yin, X., Chen, X., Zhao, Y., & Hai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1530301 · Cited by 27
The Function and Therapeutic Implications of TNF Signaling in MDSCs
Yu, K., Yu, C., Jiao, L., Miao, K., Ni, L., Rao, X., Zhou, L., & Zhao, C. (2022) · Biomolecules · doi:10.3390/biom12111627 · Cited by 18
“PBMCs also differentiated into MDSCs after the combined administration of pro-inflammatory factors TNF-α, IL-6, IL-1β, and GM-CSF [36,37] (Figure 1).”
BackgroundInfluentialMolecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System
Rybtsova, N., Berezina, T. N., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065708 · Cited by 19
MDSCs interactions with other immune cells and their role in maternal-fetal tolerance
Zhang, Y., Wang, X., Zhang, R., Wang, X., Fu, H., & Yang, W. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1938566 · Cited by 19
“D R - / lowCD33 + CD15 + CD14-, the phenotype of M-MDSCs is CD11b + HLA-DR-/lowCD33 + CD15-CD14+, and the phenotype of E-MDSCs is CD11b + HLA-DR-/ lowCD33 + CD15-CD14- [14,18] (Table 1).”
BackgroundInfluentialAging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity
Schroeter, A., Roesel, M. J., Matsunaga, T., Xiao, Y., Zhou, H., & Tullius, S. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917972 · Cited by 18
Considerations and Approaches for Cancer Immunotherapy in the Aging Host
Ontiveros, C. O., Murray, C. E., Crossland, G. E., & Curiel, T. J. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0121 · Cited by 17
Wu, J., Zhang, M., Zhang, H., Sheng, M., Sun, J., Wu, F., Gao, H., Chen, L., Li, Z., Tian, Q., et al. (2024) · Engineering · doi:10.1016/j.eng.2024.06.014 · Cited by 16
Myeloid‐Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
Su, Z., Ni, P., Zhou, C., & Wang, J. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12473 · Cited by 15
Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells
Li, Z., Zhao, Y., Zhu, C., Katz, J., Michalek, S. M., Li, Y., & Zhang, P. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.07.004 · Cited by 17
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain, S. S., Sojo, G. B., Sun, H., Friedland, B. N., McNamara, M. E., Schmidt, M. O., & Wellstein, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137013 · Cited by 18
“Using a murine model that allowed for clearance of senescent cells from the tumor microenvironment, Maggiorani et al. showed that elimination of senescent cells diminished the immunosuppressive activity of myeloid cells and resulted in improved overall survival and response to ICI [145].”
BackgroundJiménez‐Cortegana, C., Gutiérrez‐García, C., Sánchez-Jiménez, F., Vilariño‐García, T., Flores-Campos, R., Pérez‐Pérez, A., Garnacho, C., Sánchez‐León, M., García-Domínguez, D. J., Hontecillas‐Prieto, L., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5667 · Cited by 17
“CD33 is a surface cell marker that has been widely used to identify MDSCs in obesity (40) and in different types of cancer (9,41,42).”
BackgroundMURCH, S. H. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110168 · Cited by 16
Magri, S., Masetto, E., Solito, S., Francescato, S., Belluzzi, E., Pozzuoli, A., Berizzi, A., Ruggieri, P., & Mandruzzato, S. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00199-5 · Cited by 17
Circulating Muramyl Dipeptide Is Negatively Associated with Interleukin-10 in the Frail Elderly
Verschoor, C. P., Naidoo, A., Wallace, J. G., Johnstone, J., Loeb, M. B., Bramson, J. L., & Bowdish, D. M. E. (2014) · Inflammation · doi:10.1007/s10753-014-0030-z · Cited by 18
Self-citationMyeloid-derived suppressor cells, age and cancer
Bowdish, D. M. E. (2013) · OncoImmunology · doi:10.4161/onci.24754 · Cited by 14
“Since it was not known whether the aging microenvironment directly contributes to MDSC production and immunosuppression, we first assessed whether the frequency of MDSCs increases with age.(5) We observed a statistically significant increase in the percentage of both CD33HLA-DR (conventional) and CD33HLA-DRCD11bCD15 (…”
ResultSelf-citationQayyum, A., Bhosale, P., Aslam, R., Avritscher, R., Ma, J., Pagel, M. D., Sun, J., Mohamed, Y. I., Rashid, A., Beretta, L., et al. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02751-9 · Cited by 14
“Alterations in other immune cell populations, such increased myeloid-derived suppressor cells (MDSCs), that have been reported with increasing age may also be linked to skeletal muscle loss through changes in production of myokines [23, 24].”
BackgroundPadova, S. D., Urbini, M., Schepisi, G., Virga, A., Meggiolaro, E., Rossi, L., Fabbri, F., Bertelli, T., Ulivi, P., Ruffilli, F., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.564346 · Cited by 17
“Increased numbers of circulating myeloid-derived suppressor cells (MDSCs) and regulatory T-cells (Tregs) have been reported in older mice and humans, further inhibiting the antigen-induced activation of helper and cytotoxic T cells (46, 47).”
BackgroundIqbal, H., & Rhee, D. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.05.005 · Cited by 16
Verschoor, C. P., McEwen, L. M., Kobor, M. S., Loeb, M. B., & Bowdish, D. M. E. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.010 · Cited by 14
“Interestingly, those elderly participants with increased intermediate monocytes, MDSCs or activated neutrophils are more likely to have chronic conditions such as cancer, diabetes, and dementia (Verschoor et al., 2014; Verschoor et al., 2013; Verschoor et al., 2015).”
Self-citationInnamarato, P., & Pilon‐Thomas, S. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104277 · Cited by 14
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
Şirin, S., Dolanbay, S. N., & Aslım, B. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02499-0 · Cited by 14
Aging and oral squamous cell carcinoma development: the role of cellular senescence
Niklander, S. E., Aránguiz, P., Faunes, F., & Flores, R. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1285276 · Cited by 20
Gravekamp, C., & Chandra, D. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013010588 · Cited by 13
Cancer Immunoprevention and Public Health
Singh, S. K., & Dorak, M. T. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00101 · Cited by 15
Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection
Katahira, Y., Higuchi, H., Matsushita, H., Yahata, T., Yamamoto, Y., Koike, R., Ando, K., Sato, K., Imadome, K., & Kotani, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49937-w · Cited by 14
Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and Cancer
Talarico, G., Orecchioni, S., Falvo, P., & Bertolini, F. (2025) · Cancers · doi:10.3390/cancers17132251 · Cited by 14
“Evidence suggests that aging itself promotes the expansion of circulating MD-SCs [67,68].”
Shin, E., Jeong, S., Lee, J. E., Jeong, D. S., Han, D. K., Hong, S., & Lee, D. R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03684-6 · Cited by 14
Keltsch, E., Greiner, J., Wahl, L., Knape, I., Tews, D., Denkinger, M. D., Debatin, K., & Strauß, G. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00524-w · Cited by 12
“Elevated MDSC numbers are described in older adults with frailty and previous history of cancer [7].”
InfluentialAchmus, L., Ruhnau, J., Grothe, S., von Sarnowski, B., Bröker, B. M., Dressel, A., Schulze, J., & Vogelgesang, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.577971 · Cited by 11
Immune Checkpoint Inhibitors in the Aged
Isaacs, J. M., Antonia, S. J., & Clarke, J. M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01106-x · Cited by 10
AGE, AUTOIMMUNITY, AND INFLAMMATION: THE CURIOUS CASE OF IMMUNOSENESCENCE AND INFLAMM-AGING
Sundaram, T. G., & Ahmed, S. (2022) · Anti-Aging Eastern Europe · doi:10.56543/aaeeu.2022.1.1.04 · Cited by 13
“This occurs through a reduced function of monocytes, an increase in suppressor cell populations, Tregulatory cells (Tregs) and myeloid derived suppressor cells and an increase in the antiinflammatory cytokine, Interleukin-10 (IL-10) [21, 22].”
Liddy, D. D., Zhang, Z., Shirlekar, K., He, Z., Herremans, K. M., Han, S., Brant, J. O., Moore, F. D., Hughes, S. J., & Shirali, A. S. (2024) · Endocrine Related Cancer · doi:10.1530/erc-23-0341 · Cited by 15
Mortality and prognosis in herpes simplex Virus-1 encephalitis long-term follow up study
Katson, M., Gorenshtein, A., Pepys, J., Mina, Y., & Shelly, S. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123330 · Cited by 10
He, Z., Fahlberg, M. D., Takahashi, N., Slisarenko, N., Rout, N., Didier, E. S., & Kuroda, M. J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1hi1120-779r · Cited by 9
Goldeck, D., Theeten, H., Hassouneh, F., Oettinger, L., Wistuba‐Hamprecht, K., Cools, N., Tsitsilonis, O., & Pawelec, G. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.082 · Cited by 10
Collier‐Bain, H. D., Emery, A., Causer, A. J., Brown, F. F., Oliver, R., Dutton, D. A., Crowe, J., Augustine, D. X., Graby, J., Leach, S., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.023 · Cited by 14
“(PMN)-MDSCs (HLA-DR (cid:0) CD33 + CD14 (cid:0) ) ( F (1.16,20.89) = 34.80, p 0.001, η p 2 = 0.66), which increased by 70 ± 60 % ( p 0.001), 84 ± 89 % ( p = 0.045), and 65 ± 53 % ( p < 0.001) pre-to post-exercise, respectively (Supplementary Table S4).”
BackgroundInfluentialIs cancer vaccination feasible at older age?
Gravekamp, C., & Jahangir, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.025 · Cited by 10
The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
Wang, L., Luo, Y., Chen, X., Wang, Y., & Zhang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70041 · Cited by 10
Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression
Mori, H., Cardiff, R. D., & Borowsky, A. D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00035 · Cited by 9
“MDSCs are increased in aged mice (Grizzle et al., 2007; Enioutina et al., 2011) and human (Verschoor et al., 2013).”
BackgroundMatsumoto, K., Tamiya, A., Inagaki, Y., Taniguchi, Y., Matsuda, Y., Kawachi, H., Tamiya, M., Tanizaki, S., Uchida, J., Ueno, K., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.09.004 · Cited by 7
Immunosuppressive CD14+/HLA-DRlow/‒ monocytes in patients with Chagas Disease
Viana, C. E. M., Matos, D. M., Oliveira, M. D. F., da Costa, A. C., Filho, T. P. D. A., Filho, P. A. M., Nunes, F. M. M., dos Santos, T. N., Gonçalves, R. P., & Queiroz, J. Á. N. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2021.106154 · Cited by 7
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
Gulley, J. L., Repasky, E. A., Wood, L. S., & Butterfield, L. H. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0262-1 · Cited by 6
“Importantly, MDSC increase with age and a past history of cancer correlates with this increase in MDSC numbers [20].”
BackgroundSu, Y., Wu, R., Ai, H., Zhong, Z., Zou, L., Wang, Z., Tu, K., Tang, L., Gao, J., Huang, Y., et al. (2025) · npj Aging · doi:10.1038/s41514-025-00317-x · Cited by 5
Campanelli, R., Carolei, A., Catarsi, P., Abbà, C., Boveri, E., Paulli, M., Gentile, R., Morosini, M., Albertini, R., Mantovani, S., et al. (2024) · Cancers · doi:10.3390/cancers16142556 · Cited by 5
“The 1 × 10 6 low-density cells obtained after gradient centrifugation (1077 g/mL) were stained within 1 h [18], with BV421-anti-CD11b, PeCy7-anti-CD14, APC-anti-HLA-DR, PerCP-anti-CXCR4 (all Becton Dickinson, Franklin Lakes, NJ, USA), PeCy7-anti-CD15 (Thermo Fisher Scientific, Waltham, MA, USA),…”
The aging immune system: Dysregulation, compensatory mechanisms, and prospects for intervention
Müller, L., & Pawelec, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00016-0 · Cited by 5
Leonardo, L., Kenangalem, E., Poespoprodjo, J. R., Noviyanti, R., Price, R. N., Anstey, N. M., Minigo, G., & Kho, S. (2022) · Malaria Journal · doi:10.1186/s12936-022-04268-6 · Cited by 5
Safi, S., Yamauchi, Y., Hoffmann, H., Weichert, W., Jost, P. J., Winter, H., Muley, T., & Beckhove, P. (2020) · Cancers · doi:10.3390/cancers12123496 · Cited by 5
“Moreover, many studies have shown significantly increased numbers of immunosuppressive myeloid suppressor cells (MDSCs) [18] and regulatory T cells [19] in the tissues and blood of elderly patients; both of these cell types inhibit tumor-specific T cell functions and lead to tumor progression [20,21].”
BackgroundThe Role of Myeloid Derived Suppressor Cells in Urothelial Carcinoma Immunotherapy
Puttmann, K. T., Duggan, M. C., Mortazavi, A., Diaz, D. A., Carson, W. E., & Sundi, D. (2019) · Bladder Cancer · doi:10.3233/blc-190219 · Cited by 6
“found significantly higher 105 levels of circulating CD11b+CD15+ PMN-MDSC in 106 in a cohort of frail elderly individuals, as compared 107 to younger adults [17].”
ResultWang, M., Han, Y., Yao, X., Duan, X., Wan, J., Lou, X., Yan, Y., Zheng, P., Wang, F., Zhu, L., et al. (2024) · MedComm · doi:10.1002/mco2.605 · Cited by 6
“As increases of MDSCs’ expansion and activation are dependent on chronological age, 3,5,6 we established a murine ageing model, in which the age of young and old wild-type (WT) mice was 2 − 3 and 18 − 24 months, respectively.”
BackgroundImmunosenescence and Cancer Immunotherapy at Old Age: Basics
Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-44870-1_77-1 · Cited by 4
Immunosenescence and Cancer Immunotherapy at Old Age: Basics
Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_77 · Cited by 5
Wigand, M. C. C., Jeske, S. S., Hahn, J., Doescher, J., Laban, S. A., Hoffmann, T. K., & Schuler, P. J. (2019) · HNO · doi:10.1007/s00106-019-00758-3 · Cited by 5
Ishimura, D. T. M. E. (2015) · Journal of Aging Science · doi:10.4172/2329-8847.1000132 · Cited by 3
“MDSCs have been associated with inflammatory conditions such as infections and cancer and could contribute for the suppressive state observed in ageing individuals [24-26].”
BackgroundEffect of calcitriol on myeloid-derived suppressor cells in physiological aging
Perfilyeva, Y. V., Kali, A., Aben, D. S., Abdusattarova, Y., Lushova, A. V., Ostapchuk, Y. O., Tleulieva, R., Perfilyeva, A. V., Sharipov, K. O., Davlyatshin, T. I., et al. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106768 · Cited by 3
Müller, L., & Pawelec, G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00015-0 · Cited by 3
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch49 · Cited by 4
Lepone, L. M., Donahue, R. N., Grenga, I., Metenou, S., Richards, J., Heery, C. R., Madan, R. A., Gulley, J. L., & Schlom, J. (2016) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2016.2071 · Cited by 2
Effects of different hypoxia exposure on myeloid-derived suppressor cells in mice
Xu, Q., Liu, H., Ye, Y., Wuren, T., & Ge, R. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104932 · Cited by 2
Development of therapeutic cancer vaccines based on cancer immunity cycle
Zhang, J., Zheng, Y., Xu, L., Gao, J., Ou, Z., Zhu, M., & Wang, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1134-6 · Cited by 2
Xu, Y., Xing, Y., Du, Z., Zhao, R., Deng, G., Song, H., Xue, Y., & Song, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1633926 · Cited by 3
Wang, X., Huang, Q., Zuo, Z., Wang, Z., Zhang, L., & Qian, Z. (2026) · Inflammation Research · doi:10.1007/s00011-026-02222-9 · Cited by 2
Al‐Taie, A., & Köseoğlu, A. (2022) · Oncology in Clinical Practice · doi:10.5603/ocp.2021.0023 · Cited by 2
Immunosenescence and Cutaneous Malignancies
Cheng, J. Y., & Colegio, O. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-68790-2_10 · Cited by 2
Cancer, Ageing and Immunosenescence
Forones, N. M., & Bueno, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-43365-3_7 · Cited by 2
Innate Immunosenescence and Its Impact on Health in Old Age
Tariq, M. A., Hazeldine, J., & Lord, J. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-43365-3_1 · Cited by 3
Заботина, Т. Н., Panchuk, I., Tabakov, D., & Захарова, Е. Н. (2020) · Practical oncology · doi:10.31917/2103249 · Cited by 4
Breast Cancer and Immunosenescence
Provinciali, M., Pierpaoli, E., Malavolta, M., Donnini, A., Smorlesi, A., & Gatti, C. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_56 · Cited by 2
Lipid peroxidation and superoxide dismutase activity in pea seedlings under clinorotation.
Бараненко, В. В. (1998) · PubMed · Cited by 2
Metadata
- Authors
- Verschoor, C. P., Johnstone, J., Millar, J., Dorrington, M. G., Habibagahi, M., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- Shiraz University of Medical Sciences (IR)
- Corresponding author
- Bowdish, Dawn M E
- ORCID
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-01
- Volume
- 93
- Issue
- 4
- Pages
- 633-637
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- PMC
- PMC3701116
- OpenAlex
- W2095746947
- Cited by
- 235
- References
- 39
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 18 · 2023: 12 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 19 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 8
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Leukocyte Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- myeloid-derived suppressor cells, aging, frail elderly, cancer history, immunosenescence, immunosuppression, inflammatory cytokines, TNF-α, interleukin-6, IL-1β
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Cell Differentiation, Female, Fucosyltransferases, HLA-DR Antigens, Humans, Male, Middle Aged, Neoplasms, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Immunophenotyping, Lewis X Antigen, Myeloid Cells, CD11b Antigen, Interleukin-1beta, Sialic Acid Binding Ig-like Lectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.